A new study examines the capacity of health care systems to accommodate patients - among the factors that determine public health in the face of infectious disease outbreaks like COVID-19.
If the experimental coronavirus vaccines win approval from the Food and Drug Administration, they will be the first-ever authorized vaccines that use mRNA.
New findings propose strategies for reducing risk according to a rigorous understanding of the manner infectious particles "mix with air in confined spaces."